NMN clinical trials

The most recent clinical trials evaluating the effects of NMN on NAD⁺ levels and health:
[1] September 2024: 250-850g NMN, N=80, 35-65 years, Randomized, Placebo-controlled. 
[2] May 2024: 250mg NMN, N=60, 65-75 years, Randomized, Placebo-controlled, Double-Blind
[3] January 2024: 250mg NMN, N=14, 40-60 years, Single-center, Single-arm, Open-label
[4] September 2023: 800mg NMN, N=19, 18-80 years, Randomized, Open, 2-arm parallel
[5] February 2023: 125mg NMN, N=36, 40-59 years, Randomized, Placebo-controlled, Double-Blind
[6] July 2023: 2000mg NMN, N=30, >45 years, Single-center, Randomized, Placebo-controlled, Double-Blind
[7] December 2022: 300-900mg NMN, N=80, Multi-center, Randomized, Placebo-controlled, Double-Blind, Parallel Group
[8] May 2022: 250mg NMN, N=42, Placebo-controlled, Randomized, Double-blind, Parallel-group